Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Clinical trial NCT00310232 · TERMINATED
Trial details
- NCT number
- NCT00310232
- Sponsor
- Ontario Clinical Oncology Group (OCOG)
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.